Enveric Biosciences Opens Bidding Process for PsyAI™ Trademark Portfolio Amid Focus on Drug Development March 12, 2025
Archon Biosciences Launches with $20M Seed Funding to Boost Drug Development Using AI-Driven ‘Antibody Cages’ November 1, 2024
Pathos AI Closes $62M Oversubscribed Series C Round of Financing to Accelerate its Platform Approach to Drug Development October 29, 2024
Formation Bio Secures $372M Series D Funding to Grow Drug Pipeline and Continue Expanding AI-driven Drug Development Platform June 30, 2024
Cognivia Secures Strategic €15.5M Funding to Empower Drug Development with AI-ML Solutions April 21, 2024
BioPhy Launches Breakthrough AI Platform to Accelerate the Trillion Dollar Drug Development Market November 13, 2023
Simbec-Orion & biotx.ai Launch Strategic Partnership to De-risk Early-stage Drug Development with AI-Supported Clinical Trial Design November 8, 2023
Enveric Biosciences Opens Bidding Process for PsyAI™ Trademark Portfolio Amid Focus on Drug Development March 12, 2025
Archon Biosciences Launches with $20M Seed Funding to Boost Drug Development Using AI-Driven ‘Antibody Cages’ November 1, 2024
Pathos AI Closes $62M Oversubscribed Series C Round of Financing to Accelerate its Platform Approach to Drug Development October 29, 2024
Formation Bio Secures $372M Series D Funding to Grow Drug Pipeline and Continue Expanding AI-driven Drug Development Platform June 30, 2024
Cognivia Secures Strategic €15.5M Funding to Empower Drug Development with AI-ML Solutions April 21, 2024
BioPhy Launches Breakthrough AI Platform to Accelerate the Trillion Dollar Drug Development Market November 13, 2023
Simbec-Orion & biotx.ai Launch Strategic Partnership to De-risk Early-stage Drug Development with AI-Supported Clinical Trial Design November 8, 2023
